ARTES Biotechnology
To describe ARTES Biotechnology in a nutshell, we are a global, well-established, and reliable technology provider for recombinant protein production. We are experts in the development of microbial cell lines and processes for the target protein of your choice – be it a vaccine, biopharmaceutical, biosimilar and/or enzyme. We also offer a wide range of ready-to-transfer processes for a variety of products.
Our highly experienced team is available for custom projects to provide the most efficient solution. We are experts in troubleshooting and setting up manufacturing processes.
All platform technologies (cell lines and antigen presentation) have “freedom-to-operate” and are protected by patents and trade secrets. ARTES is available to negotiate exclusive licensing terms.
International registrations including US-FDA, EMA and non-regulated market approvals, GRAS certifications and WHO recommendations are part of our track record in international collaborations. Large scale manufacturing and full cGMP analytical services are provided in collaboration with partners.